OECD Working Group on Good Laboratory Practice. Template for submission of comments on draft GLP Guidance Documents. Instructions for Use
|
|
- Alban Parsons
- 6 years ago
- Views:
Transcription
1 OECD Working Group on Good Laboratory Practice Template for submission of comments on draft GLP Guidance Documents Instructions for Use 1. First, please complete the table below giving the full name of the draft document and your name and contact details. Comments received without the identity of the submitter may not be considered by the Working Group. Full Name of Document: OECD DRAFT ADVISORY DOCUMENT 16: THE APPLICATION OF GLP PRINCIPLES TO COMPUTERISED SYSTEMS (Draft OECD Guidance Document, 16 September 2014) Submitter s Name: Greg Furrow Position in Organisation: President Organisation / Affiliation: Society of Quality Assurance Address 154 Hansen Road, Suite 201, Charlottesville, VA USA Country / Economy USA (United States of America) Greg.Furrow@wilresearch.com; michael.regehr@basf.com Date: 14 NOV Second, insert your comments into the template attached using the following instructions: (i) Go into the header of the template and enter the full name of the document. This will ensure this critical information appears on each page. (ii) Column 1: Please enter a commonly accepted two or three letter abbreviation code for your country or economy. Do this for each comment. This information is critical for the Working Group to collate and review comments and to assist in identifying the source of the comment. (iii) Column 2: Please enter the line number (or paragraph number and line number within the paragraph, depending on how the document is presented) of the text you wish to comment on. (iv) Column 3: Please include your comment (including the affected text if appropriate), along with any justification. (v) Column 4: Please indicate what change you would like to make to the text as a result of your comment. Where relevant, please provide any proposed new wording. (vi) Column 5: This is for OECD WG use only. 3. Finally, once completed, please forward your comments to the appropriate authority (see Instructions) Thank you for your contribution to the work of the OECD Working Group on Good Laboratory Practice. 4 July 2014
2 . / USA 11 Please reference PIC/S and Red Apple II for both prospective and retrospective validations. Change Guidance for the validation of legacy systems is given by PIC/S PI 11-3 Good Practices for Computerised Systems in Regulated GxP Environments [effective ]. USA 16 Please match wording to paragraph 34 and Table 1 (page 21). To Guidance for the validation of computerised systems is given by PIC/S PI 11-3 Good Practices for Computerised Systems in Regulated GxP Environments [effective ] and Computerized Systems used in Nonclinical Safety Assessment: Current Concepts in Validation and Compliance [published 2008, DIA, Red Apple II ]. Change Management of a test facility To Test Facility Management USA 17/1 Study Directors and QA personnel may not be involved in each specific validation procedures. This is generally the responsibility of the system owner and designated support personnel. USA 18 Please reword to better define fully aware of the involvement. Change in any validation-relevant tasks To in the overall validation program Change The Study Directors should be fully aware of the involvement of any computerised system used in studies under their direction. Study Directors have the responsibility to ensure that computerised systems used in their studies are validated. To Study Directors have the responsibility to ensure that any and all computerised systems used in their studies are validated and used appropriately. USA 19 Please expand on the term specialist techniques. Change Quality Assurance personnel should be given training in any specialist techniques necessary. To Quality Assurance personnel should be given training in any special computer processes needed (system user training, audit trail reviewing, data analysis techniques, etc). USA 19 Please clarify read-only access to the data. Change Quality Assurance personnel should have, for data review, direct read-only access to the data stored within a computerised system. To During data review, Quality Assurance personnel should have direct read-only access to the data if only available within a computerised system. page 2 of 6
3 . / USA 20 Study Directors and QA personnel may not be involved in each specific validation procedures. This is generally the responsibility of the system owner and designated support personnel. USA 20, et al Please standardize spelling of computerised. See also paragraphs 40, 46, 50, 51. USA 21 Unless computer system technical standards are to be recognized, this should be more general. See also Table 2 Glossary. USA 28 Third-parties agreement may exist with the enterprise as a whole, rather than the GLP test facility alone. Formal agreements would be written agreement (as in paragraph 30). Please use just one term written agreement. Change understand their relevant procedures To understand the relevant procedures Change in any validation-relevant tasks To in the overall validation program Change computerized To computerised Change recognized technical standards To best practice guidances and standards Change formal agreements must exist between the GLP facility and any third parties To written agreements must exist for any third-party support of a GLP facility USA 31/5 Please clarify validation system. Change his quality assurance / risk manage-ment / validation system To quality assurance and validation procedures USA 38 Please use common format. See paragraph 39, 94. USA 39 Excellent common example. Minor wording enhancements are suggested to distinguish the spreadsheet from the COTS product. Change should be evaluated by the facility s validation system To should be reviewed as part of the facility s validation procedures Change "spread-sheet" To spreadsheet Change Spreadsheet templates for calculations using predefined formulas or self-written code should be regarded as an in-house developed application. As the qualification of the underlying COTS product has no relevance for the application, validation and documentation according chapter 2 and 3 is required. To Each spreadsheet template for calculations using pre-defined formulas, self-written equations, or macros should be validated and documented as an in-house developed application according chapters 2 and 3. Qualification of the underlying COTS product alone is not sufficient. page 3 of 6
4 . / USA 46 Please use English in place of Latin. Change inter alia to among other things USA 47 Source code may not be available to the regulated user for some COTS. The primary concern should be for limited-use or bespoke applications. See also Paragraph 75. USA 49(e) System performance can be assessed by evaluating the ongoing operations (live data transfers, user access) and may include new testing (example data processing, stress conditions). USA 54/2 Please specify that system inventory need not include each non-glp systems in addition to the GLP-relevant systems. Detailed inventory of all non-glp lab equipment, scales, calculators, cash registers, ATMs, laptops, VoIP phones, and smartphones would be a large and unproductive task. Change Some OECD Member countries require that the source code for application software should be available at, or retrievable to, the test facility. To Source code of bespoke systems (or all application software in some OECD Member countries) should be retrievable by the regulated user to provide the monitoring authority access to the software code. This can be done by archiving a digital copy of the source code, escrow arrangements, or service level agreements. Change periodic testing To periodic evaluation Change The list should cover non-glp-relevant systems as well To The regulated user should also describe general machine types, software, or uses that are non-glp-relevant systems USA 67 Please match wording to paragraph 56. Change retrospectively validated systems To retrospectively evaluated systems USA 69 Please use the common reference format. Change ISO/9001 To ISO 9001 USA 75 Source code may not be available to the regulated user for some COTS. The primary concern should be for limited-use or bespoke applications. See also paragraph 47. To USA 77 Please specify that a supplier s IQ/OQ activities and documentation can supplement or replace testing by the regulated user as expressed in GAMP5. Change Source code of bespoke systems should be retrievable by the regulated user to provide the monitoring authority access to the software code. Source code of bespoke systems should be retrievable by the regulated user to provide the monitoring authority access to the software code. This can be done by archiving a digital copy of the source code, escrow arrangements, or service level agreements. Change All systems, including purchased systems (e.g. an HPLC system), need to be tested and evaluated by the regulated user. To The regulated user must ensure all systems, including purchased systems (e.g. an HPLC system), are tested and evaluated. A supplier s IQ/OQ activities and documentation may supplement or replace testing by the regulated user. page 4 of 6
5 . / USA 84/2-3 Suggest maintaining the language found in EU GMP Annex 11. Change "meaningfulness" To value and/or meaning USA 87 Please use common format. See paragraph 39, 94. Change " spread sheets " To spreadsheets USA 102/2-3 The raw data respecting the histopathological evaluation of a study is the signed dated pathologist report. Notes created by a pathologist during the histopathological evaluation of a study are not raw data. USA 105 Printing some original raw data in a human-readable format (which is the perceived goal) is problematic or futile because of proprietary storage formats. Data integrity and audit accessibility are important. USA 106 Only printouts created after the data modification can reflect the change. Printouts from a computerised system may also reflect an independent audit trail as explained in paragraph 111. USA Suggest use of Audit Trail to distinguish from a QAU activity of auditing. Remove written observations and conclusions as written by a pathologist, Change print all electronic records (including raw data and derived data) To print or otherwise provide human-readable copies of all electronic records (as raw data or derived reports, as appropriate for data integrity and auditing) Change in printed copies. To in later printed copies. Audit trails may exist in some systems as a record of changes independent of the view to the data (on screen or printed). Change The regulated user should audit To The regulated user should audit trail Change If audit policies for the application To If audit trailing policies for the application USA 115, 118 Suggest the term validated in place of valid. Change valid status of the system To validated status of the system USA 116 Suggested language for clarification and addition of configuration management. USA 141/3-5 Overall responsibility would be on the regulated user (test facility management delegating to the system owner), and uncertain of the task for each role listed. Change should be within the system description and need not be part of change management To need not be part of formal change or configuration management if properly explained in the system description Change Facility management, study director and quality assurance To The regulated user page 5 of 6
6 . / USA Please rephrase to clarify release of data is not a new requirement in GLP. USA 166/2 Software backup copies may not be provided to the regulated user from all vendors. USA Table 1: Regulated User USA Table 2: Recognised Technical Standards Responsibilities are delegated by Test Facility Management to the appropriate staff. Unless computer system technical standards are to be recognized specifically, this should remain more general. See also paragraph 21. Change Electronic release of data should be performed using an electronic signature. The electronic data approval / release process should be documented in detail. To If a procedure includes an electronic data approval / release process, it should be documented in detail and performed using an electronic signature. Change maintained To maintained, escrowed, or available by service level agreement. Change represented by the test facility management. To represented by the Test Facility Management, will delegated duties to System Owners, IT Personnel, Validation Directors, Study Directors, and Quality Assurance. Remove entry for Recognized technical standards page 6 of 6
GLP Computerized Systems Updates from OECD Guidance. Dr. Michael Regehr, BASF Corporation 28 JAN 2016, NAICC, Orlando
GLP Computerized Systems Updates from OECD Guidance Dr. Michael Regehr, BASF Corporation 28 JAN 2016, NAICC, Orlando 1 Validation EPA GLP Obligation Expectations of the EPA for Computers in GLP (40 CFR
More informationMASTER VALIDATION PLAN PROCEDURE DRAFT DRAFT OF A POSSIBLE COMPUTER SYSTEMS VALIDATION MASTER PLAN PROCEDURE
DRAFT OF A POSSIBLE COMPUTER SYSTEMS VALIDATION MASTER PLAN PROCEDURE 1. PURPOSE The purpose of this SOP is to define the minimum requirements for Computer Systems Validation (CSV) at (insert name of company
More informationEnterprise and Industry Directorate-General European Commission B-1049 Brussels Belgium BY TO and
1201 Maryland Avenue SW, Suite 900, Washington, DC 20024 202-962-9200, www.bio.org 31 October 2008 Enterprise and Industry Directorate-General European Commission B-1049 Brussels Belgium BY EMAIL TO entr-gmp@ec.europa.eu
More informationEUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union
EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL Consumer goods Pharmaceuticals Brussels, 08 April 2008 EudraLex The Rules Governing Medicinal Products in the European Union Volume 4 EU
More informationEU Annex 11 update. An ISPE interpretation
EU Annex 11 update An ISPE interpretation ISPE Interpretation Published by Winnie Cappucci Chris Clark Tim Goossens Sion Wyn Disclaimer ISPE cannot ensure and does not warrant that computerized systems
More informationEU Annex 11 US FDA 211, 820, 11; other guidelines Orlando López 11-MAY-2011
Principle. a. This annex applies to all forms of computerised systems used as part of a GMP regulated activities. A computerised system is a set of software and hardware components which together fulfill
More informationEU GMP - Annex 11 Computerised systems Versione corrente Nuova versione per commenti (emessa 8 aprile 2008)
EU GMP - Annex 11 Computerised systems Versione corrente Nuova versione per commenti (emessa 8 aprile 2008) Principle The introduction of computerised systems into systems of manufacturing, including storage,
More informationCOMPUTERISED SYSTEMS
ANNEX 11 COMPUTERISED SYSTEMS PRINCIPLE This annex applies to all forms of computerised systems used as part of a GMP regulated activities. A computerised system is a set of software and hardware components
More informationEU Annex 11 US FDA , (g), (i), 11 Orlando López 09-APR
Principle. a. This annex applies to all forms of computerised systems used as part of a GMP regulated activities. A computerised system is a set of software and hardware components which together fulfill
More informationReferences Concept. Principle. EU Annex 11 US FDA , (g), (i), 11 Orlando Lopez 2/15/11. Old Annex 11.
References Concept Principle a. This annex applies to all forms of computerised systems used as part of a GMP regulated activities. A computerised system is a set of software and hardware components which
More informationCUSTOMER AND SUPPLIER ROLES AND RESPONSIBILITIES FOR 21 CFR 11 COMPLIANCE ASSESSMENT. 21 CFR Part 11 FAQ. (Frequently Asked Questions)
21 CFR Part 11 FAQ (Frequently Asked Questions) Customer and Supplier Roles and Responsibilities for Assessment of METTLER TOLEDO STARe Software Version 16.00, including: - 21 CFR 11 Compliance software
More informationComputerised Systems. Alfred Hunt Inspector. Wholesale Distribution Information Day, 28 th September Date Insert on Master Slide.
Computerised Systems Wholesale Distribution Information Day, Alfred Hunt Inspector Date Insert on Master Slide Slide 1 Index What is a computerised system Updates to EU GDPs Expectations Case studies Slide
More informationEUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union
EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Public Health and Risk Assessment Pharmaceuticals Brussels, SANCO/C8/AM/sl/ares(2010)1064599 EudraLex The Rules Governing Medicinal Products
More informationComputerised Systems. Inspection Expectations. Paul Moody, Inspector. 18/10/2013 Slide 1. ISPE GAMP COP Ireland Meeting, Dublin, 17 th October 2013
Computerised Systems Inspection Expectations ISPE GAMP COP Ireland Meeting, Dublin, 17 th October 2013 Paul Moody, Inspector Slide 1 Presentation Contents Brief Introduction to the IMB Regulatory References
More informationComputer System Validation Perform a Gap Analysis of your CSV Processes
Computer System Validation Perform a Gap Analysis of your CSV Processes Chris Wubbolt, QACV Consulting Computer and Software Validation Conference April 27, 2017 www.qacvconsulting.com 1 Objectives Computer
More informationRegulatory Overview Annex 11 and Part 11. Sion Wyn Conformity +[44] (0)
Regulatory Overview Annex 11 and Part 11 Sion Wyn Conformity +[44] (0) 1492 642622 sion.wyn@conform-it.com 1 Two Key Regulations Annex 11 21 CFR Part 11 Apply to the regulated company, but often have a
More informationSummary of Significant Changes. Policy
This Policy replaces POL251/1 Copy Number Effective 03/04/17 Summary of Significant Changes Addition of requirements of 2016 review of Guidance by MHRA, ALCOA+, and documents related to Policy The purpose
More informationPART 58 GOOD LABORATORY PRACTICE FOR NONCLINICAL LABORATORY STUDIES
Part 58-explanation of changes Scope ( 58.1) We propose to expand the scope of FDA-regulated nonclinical laboratory studies to specifically include toxicity studies. For purposes of this proposal, toxicity
More informationPART 58 GOOD LABORATORY PRACTICE FOR NONCLINICAL LABORATORY STUDIES
Part 58-explanation of changes Scope ( 58.1) We propose to expand the scope of FDA-regulated nonclinical laboratory studies to specifically include toxicity studies. For purposes of this proposal, toxicity
More informationSPAQA GLP Monitoring Authority Roundtable 2017
General Questions 1. Information flow Would it be possible for the GLP notification office to inform SPAQA (vorstand@spaqa.ch) of changes to the Swiss Monitoring Authorities website (e.g. new OECD guidelines,
More informationGeneral European OMCL Network (GEON) QUALITY MANAGEMENT DOCUMENT
General European OMCL Network (GEON) QUALITY MANAGEMENT DOCUMENT PA/PH/OMCL (08) 69 R7 VALIDATION OF COMPUTERISED SYSTEMS CORE DOCUMENT Full document title and reference Document type Validation of Computerised
More informationISPE NORDIC COP CLEAN UTILITIES SEPTEMBER TUUSULA FINLAND. Timo Kuosmanen STERIS Finn-Aqua
ISPE NORDIC COP CLEAN UTILITIES SEPTEMBER 7 2016 TUUSULA FINLAND Timo Kuosmanen STERIS Finn-Aqua Timo_Kuosmanen@steris.com AUDIT TRAIL IN CRITICAL UTILITIES MONITORING CURRENT TRENDS CONTENTS BACKGROUND
More informationComputerised System Validation
Computerised System Validation Considerations for the Validation Lifecycle Paul Moody GMP Conference 12 th November 2014 Regulatory References EU GMP Annex 11 (2011) http://ec.europa.eu/health/files/eudralex/vol-4/annex11_01-2011_en.pdf
More informationWhite paper: Code of GMP Chapter 4 Documentation - PIC/S versus EU
White paper: Code of GMP Chapter 4 Documentation - PIC/S versus EU Numerous articles are available comparing the current and previous EU Code of GMP Chapter 4: Documentation, but no comparison exists between
More information1201 Maryland Avenue SW, Suite 900, Washington, DC ,
1201 Maryland Avenue SW, Suite 900, Washington, DC 20024 202-962-9200, www.bio.org February 22, 2011 Dockets Management Branch (HFA-305) Food and Drug Administration 5600 Fishers Lane, Rm. 1061 Rockville,
More informationSwiss Interpretation of the GLP Principles 2017 State: June 13, 2017
Swiss Agency for Therapeutic Products Swiss Interpretation of the GLP Principles 2017 State: June 13, 2017 This document contains joint guidelines for the interpretation of GLP Principles according to
More informationGood Laboratory Practice GUIDELINES FOR THE VALIDATION OF COMPUTERISED SYSTEMS. Release Date:
AGIT: Swiss Working Group on Information Technology in a GLP Environment Good Laboratory Practice GUIDELINES FOR THE VALIDATION OF COMPUTERISED SYSTEMS Release Date: 31.01.2018 Version: 3.0 TABLE OF CONTENTS
More informationRegulations in Pharmaceutical Laboratories
Regulations in Pharmaceutical Laboratories February 2004 Ludwig Huber Compliance Fellow for Life Sciences and Chemical Analysis Chairperson: Rob Sample Regulations and Quality Standards Developed by Industries
More informationLEVERAGING YOUR VENDORS TO SUPPORT DATA INTEGRITY:
LEVERAGING YOUR VENDORS TO SUPPORT DATA INTEGRITY: QUESTIONS TO ASK AND RESPONSIBILITIES TO DOCUMENT Heather Longden Boston Chapter Educational Meeting April 2018 About Waters Lab Informatics Separations
More informationDATA INTEGRITY ASSURANCE AS KEY FACTOR FOR SURVIVING CORPORATE AUDITS AND REGULATORY INSECTIONS
GLOBAL PROVIDER, LOCAL SOLUTIONS IN YOUR LANGUAGE DATA INTEGRITY ASSURANCE AS KEY FACTOR FOR SURVIVING CORPORATE AUDITS AND REGULATORY INSECTIONS Francesco Amorosi PhD Octorber 2017 DATA INTEGRITY & CSV:
More informationThe Role of the LMS in 21 CFR Part 11 Compliance
The Role of the LMS in 21 CFR Part 11 Compliance Co-author: Dr. Bob McDowall, Director R.D. McDowall Limited ABSTRACT The purpose of this white paper is to describe how NetDimensions Learning addresses
More informationData Integrity. Requirements for a GMP-compliant Data Life Cycle SPEAKERS: May 2017, Budapest, Hungary LEARNING OBJECTIVES:
Data Integrity Requirements for a GMP-compliant Data Life Cycle All participants get a free copy of the current version of the ECA Data Governance and Data Integrity for GMP Regulated Facilities Guidance
More informationRisk-based Approach to Part 11 and GxP Compliance
Welcome to our E-Seminar: Risk-based Approach to Part 11 and GxP Compliance 1 Intro Common Discussion Q: Do I really need to do this? Possible Answers A: Of course! (QA) B: Who cares, I have work to do!
More informationAudit Trail Review / Data Integrity
Audit Trail Review / Data Integrity Requirements for a GMP-compliant Data Life Cycle Comments on the FDA Draft Guidance for Industry Data Integrity and Compliance with cgmp and on the new GAMP Records
More informationá1058ñ ANALYTICAL INSTRUMENT QUALIFICATION
USP 41 General Information / á1058ñ 1 á1058ñ ANALYTICAL INSTRUMENT QUALIFICATION INTRODUCTION A large variety of analytical instruments, ranging from a simple apparatus to complex computerized systems,
More informationPROPOSED NEW SECTIONS FOR WHO GOOD MANUFACTURING PRACTICES (GMP): MAIN PRINCIPLES FOR PHARMACEUTICAL PRODUCTS DRAFT FOR COMMENT
August 2010 RESTRICTED PROPOSED NEW SECTIONS FOR WHO GOOD MANUFACTURING PRACTICES (GMP): MAIN PRINCIPLES FOR PHARMACEUTICAL PRODUCTS DRAFT FOR COMMENT Please address any comments on this draft guideline
More informationData Integrity Through the Life Cycle Balancing Quality and Innovation. Sion Wyn Conformity +44 (0)
Data Integrity Through the Life Cycle Balancing Quality and Innovation Sion Wyn Conformity +44 (0) 1492 642622 sion.wyn@conform-it.com Theme Achieving harmony Balancing quality, safety, and compliance
More informationOracle Tech Cloud GxP Position Paper December, 2016
Oracle Tech Cloud GxP Position Paper Page 1 of 29 Oracle Tech Cloud GxP Position Paper December, 2016 Prepared By: Subbu Viswanathan, Head of Solutions Reviewed By: David Blewitt, VP Cloud Compliance Oracle
More informationGOOD PRACTICES FOR COMPUTERISED SYSTEMS IN REGULATED GXP ENVIRONMENTS
PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PI 011-2 1 July 2004 PIC/S GUIDANCE GOOD PRACTICES FOR COMPUTERISED SYSTEMS IN REGULATED GXP ENVIRONMENTS PIC/S July 2004
More informationData Integrity: Production Environment
Data Integrity: Production Environment MANUAL AND AUTOMATED SYSTEMS Ciara Turley GMP Conference 12 th November 2014 Content GMP Guide requirements and application to processing equipment Security Audit
More informationfor Data Integrity Requirements for a GMP-compliant Data Life Cycle With an optional full-day pre-course session Audit Trail Review SPEAKERS:
Data Integrity Requirements for a GMP-compliant Data Life Cycle With an optional full-day pre-course session Audit Trail Review SPEAKERS: Bob McDowall R.D. McDowall Ltd. Karl-Heinz Menges Regierungspräsidium
More informationGAMP Guideline & Validation Documentation
GAMP Guideline & Validation Documentation Danilo Maruccia Milano, 21 Marzo 2006 GAMP Guideline & Validation Documentation GAMP Guideline Planning documents Specification Documents Testing Documents Acceptance
More informationCross-walk between EU Annex 11 and US FDA 211, 820, 11; other guidelines and regulations Orlando López Rev22APR16
Principle. a. This annex applies to all forms of computerised systems used as part of a GMP regulated activities. A computerised system is a set of software and hardware components which together fulfill
More informationCOMPUTERIZED SYSTEM VALIDATION
www.kevintech.com Current Practices of COMPUTERIZED SYSTEM VALIDATION Kevin ISSUE.1/2017 CONNECT INSIDE - Basics of Computerized System Validation - Life Cycle of Computerized System The less manual the
More informationSIMATIC IT. SIMATIC IT R&D SUITE V7.1 Compliance Response ERES. Introduction 1. The Requirements in Short 2
Introduction 1 The Requirements in Short 2 SIMATIC IT Meeting the Requirements with SIMATIC IT R&D Suite V7.1 3 SIMATIC IT R&D SUITE V7.1 Evaluation List for SIMATIC IT R&D Suite V7.1 4 Product Information
More informationDevelop a Roadmap for the Implementation of a Global CSV Program. Eileen Cortes April 26, 2017
Develop a Roadmap for the Implementation of a Global CSV Program Eileen Cortes April 26, 2017 Agenda CSV Regulation Principles CSV Lifecycle Approach CSV and Quality Management Governance Program and CSV
More informationData Integrity. Requirements for a GMP-compliant Data Life Cycle SPEAKERS: August 2017, Copenhagen, Denmark LEARNING OBJECTIVES:
Data Integrity Requirements for a GMP-compliant Data Life Cycle All participants get a free copy of the current version of the ECA Data Governance and Data Integrity for GMP Regulated Facilities Guidance
More informationCross-walk between EU Annex 11 and US FDA 211, 820, 11; other guidelines and regulations Orlando López Rev05MAR15
Principle. a. This annex applies to all forms of computerised systems used as part of a GMP regulated activities. A computerised system is a set of software and hardware components which together fulfill
More informationLab Data Integrity. Meeting FDA & EU Concerns. Part 1: Establishing the Controls for Ensuring Laboratory Data Integrity
Lab Data Integrity Meeting FDA & EU Concerns All participants get a free copy of the current version of the ECA Data Governance and Data Integrity for GMP Regulated Facilities Guidance SPEAKERS: Dr Christopher
More informationLatino America Consultores Innovation & Technology to make your Business Compliant
Latino America Consultores Innovation & Technology to make your Business Compliant Annex 15 & EMA Process Validation Guide Line 1 Changes in Requirements The Pharmaceutical Industry has adapted its business
More informationCross-walk between EU Annex 11 and US FDA 211, 820, 11; other guidelines and regulations Orlando López Rev11AUG16
Principle. a. This annex applies to all forms of computerised systems used as part of a GMP regulated activities. A computerised system is a set of software and hardware components which together fulfill
More informationCross-walk between EU Annex 11 and US FDA 211, 820, 11; other guidelines and regulations Orlando López Rev19Dec14
Principle. a. This annex applies to all forms of computerised systems used as part of a GMP regulated activities. A computerised system is a set of software and hardware components which together fulfill
More informationRegulatory Expectations, Standards & Guidelines
Regulatory Expectations, Standards & Guidelines Regulatory Requirements Pharmacopeias Good Automated Manufacturing Practice (GAMP) 21 CFR Part 11 and Annex 11 Consequences of Non-Compliance 22 Regulatory
More informationplease fill out here:
If the bill-to-address deviates from the specifications on the right, please fill out here: Reservation Form (Please complete in full) Data Integrity Requirements for a GMP-compliant Data Life Cycle 10
More informationPreparing for a Software Quality Audit
Preparing for a Software Quality Audit By Praxis Life Sciences 1925 West Field Court, Suite 125, Lake Forest, IL 60045 praxislifesciences.com +1(847) 295-7160 validationcenter.com Preparing for a Software
More informationEnsure Data Integrity Compliance Enterprise-Wide
Ensure Data Integrity Compliance Enterprise-Wide PharmaQual 360 º Conference February 24, 2017 Chris Wubbolt QACV Consulting, LLC www.qacvconsulting.com 1 Objectives What is data integrity and the definition
More informationCurrent quality status of CABETs environmental laboratory and necessary steps to meet GLP requirements
Current quality status of CABETs environmental laboratory and necessary steps to meet GLP requirements June 18 22, 2007 Paul de Bie (Alterra) Jiang Hui (ICAMA) Workshop Report WP1 1 Beijing / Wageningen,
More informationGood Laboratory Practice CHANGE MANAGEMENT AND RISK ASSESSMENT OF VALIDATED COMPUTERISED SYSTEMS IN A GLP ENVIRONMENT. Release Date:
AGIT: Swiss Working Group on Information Technology in a GLP Environment Good Laboratory Practice CHANGE MANAGEMENT AND RISK ASSESSMENT OF VALIDATED COMPUTERISED SYSTEMS IN A GLP ENVIRONMENT Release Date:
More informationCurriculum Vitae Dr. Joachim Schoch-Bösken. jsb-validierung Zwischen den Bächen 9 D Rheinfelden
Personal Data Name Title Validation Consultant Contact jsb-validierung Zwischen den Bächen 9 D 79618 Rheinfelden Tel: +49 7623 79 49 82 Mobile: +49 176 42 60 85 72 E-Mail: Internet: jsb-val@online.de http://www.jsb-validierung.de
More informationUse of computerised equipment, software and systems in clinical research
Standard Operating Procedures (SOP) for: Use of computerised equipment, software and systems in clinical research SOP Number: 38a Version Number: 1.0 Effective Date: 21/3/16 Review Date: 21/8/17 Author:
More informationPACIFIC RIM CONSULTING COMMENTS ON FDA PROPOSAL TO REVISE GLPS
PACIFIC RIM CONSULTING COMMENTS ON FDA PROPOSAL TO REVISE GLPS 1. GLP Quality System While many of the requirements of the existing regulation are consistent with a GLP quality system, FDA believes that
More informationCurrent Trends in Data Quality and Integrity Issues in Inspections and Risk Based Approach to Investigations; EU perspective
Current Trends in Data Quality and Integrity Issues in Inspections and Risk Based Approach to Investigations; EU perspective Mark Birse / Richard Andrews, MHRA Data Integrity has no relationship with product
More informationData Integrity Why is it important? DADM Conference - 22 August 2017
Data Integrity Why is it important? DADM Conference - 22 August 2017 Maibritt Haugaard Møller, System Validation Expert Mette Ravn, Vice President, Data Management, IT and System Validation Overview of
More informationPaperless recorders and 21 CFR part 11 compliance Videographic recorders
Sales guide SG/RandC/002 EN Paperless recorders and 21 CFR part 11 compliance Videographic recorders Introduction Today's manufacturing environment is becoming more regulated than ever and the most well
More informationSESSION 14. Documentation Requirements and Management for Validation. 30 March Frits Vogt
Validation Services SESSION 14 Documentation Requirements and Management for Validation 30 March 2017 Frits Vogt fritsvogt@valserv.nl Content Documentation Requirements and Management for Validation I.
More informationSystem Requirements (URS)
System s (URS) System Document Control System Document ID URS000XXX Version 1 DOCUMENT APPROVALS Reason For Signature Name Position Signature Date Prepared by Vic Johnson Project Manager Checked for accuracy
More informationRequirements for a GMP-compliant Data Life Cycle May 2016, Berlin, Germany. Karl-Heinz Menges Regierungspräsidium Darmstadt
Data Integrity Workshops on: Analysis of FDA Warning Letters Key Data Integrity Topics / Criteria Assessing a System for Data Integrity Requirements for a GMP-compliant Data Life Cycle 17-19 May 2016,
More informationStrategies for Risk Based Validation of Laboratory Systems
Strategies for Risk Based Validation of Laboratory Systems Video Web Seminar September 23, 2004 Ludwig Huber E-mail: ludwig_huber@agilent.com Today s Agenda Background information: why risk assessment,
More informationRegulations and guidance for the pharmaceutical industry
w w w. spec troscopyonline. com April 2011 Spectroscopy 26(4) 1 Focus on Quality Is GMP Annex 11 Europe s Answer to 21 CFR 11? January 2011 saw the publication of the new revision of European Union (EU)
More informationContents. Contents (13) 1 Qualification (21)
1 Qualification (21) 1.A Official requirements (23) 1.A.1 Legal aspects of qualification (23) 1.A.2 Documentation of the qualification (26) 1.A.3 Design Qualification (DQ) (27) 1.A.4 Installation Qualification
More informationGOOD LABORATORY PRACTICE (GLP)
GOOD LABORATORY PRACTICE (GLP) Series Catalog CITI Program s GLP series provides an overview of how nonclinical laboratory studies should be planned, performed, monitored, recorded, reported, and archived
More informationGood Laboratory Practice. GUIDELINES FOR THE MANAGEMENT OF ELECTRONIC STANDARD OPERATING PROCEDURES (SOPs) IN A GLP ENVIRONMENT
AGIT: Swiss Working Group on Information Technology in a GLP Environment Good Laboratory Practice GUIDELINES FOR THE MANAGEMENT OF ELECTRONIC STANDARD OPERATING PROCEDURES (SOPs) IN A GLP ENVIRONMENT Release
More informationEstablishing the Self Inspections and Controls for Ensuring Audits to Confirm Effective Laboratory Data Integrity, Data Integrity Controls,
Lab Data Integrity Meeting FDA & EU Concerns SPEAKERS: Dr Christopher Burgess Chairman of the ECA Analytical Quality Control Working Group Dr Bob McDowall Member of the ECA IT Compliance Interest Group
More informationValidation Documentation. Presented by John Montalto 27 March, 2013
Validation Documentation Presented by John Montalto 27 March, 2013 Validation planning Validation policies define management intent and commitment Validation Master Plans (VMPs) Individual Validation Plans
More information21 CFR Part 11 Compliance for SaaS/Cloud Applications
21 CFR Part 11 Compliance for SaaS/Cloud Applications *** LIMITED TIME OFFER: FREE $100 AMAZON GIFT CARD! *** REGISTER TODAY! This highly interactive two-day course uses real life examples and explores
More informationReduce costs for compliance with data integrity: 21 CFR Part 11, SaaS/Cloud, EU GDPR
Reduce costs for compliance with data integrity: 21 CFR Part 11, SaaS/Cloud, EU GDPR *** LIMITED TIME OFFER: FREE $100 AMAZON GIFT CARD! *** REGISTER TODAY! This highly interactive two-day course uses
More informationSubject: EU Guidelines for Good Manufacturing Practice for Medicinal Products for Human and Veterinary Use, Annex 15: Qualification and Validation
29 May 2014 EUROPEAN COMMISSION Health and Consumers Directorate-General Subject: EU Guidelines for Good Manufacturing Practice for Medicinal Products for Human and Veterinary Use, Annex 15: Qualification
More informationLibrary Guide: Active Pharmaceutical
Library Guide: Active Pharmaceutical Ingredients (API) Table of Contents Overview...3 Sample Curriculum...5 Course Descriptions: A Step-by-Step Approach to Process Validation (PHDV79)...7 A Tour of the
More informationEffective Management and Operations of GXP Laboratories
Effective Management and Operations of GXP Laboratories Course Objective: Upon completion of this course, attendees involved in establishing and assuring that Good Laboratory / Good Manufacturing Practice
More informationEUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY. EudraLex. Volume 4
EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY Ref. Ares(2015)4234460-12/10/2015 Medicinal products quality, safety and efficacy Brussels, 12 October 2015 EudraLex Volume 4 EU Guidelines
More informationGood Distribution Practices Toolkit Change Control 10 March 2016
Good Distribution Practices Toolkit Change Control 10 March 2016 1 Disclaimer The content of this presentation were derived mainly from WHO training material on Change Control and edited to suit the Distributor
More informationWorking Party on Control of Medicines and Inspections. Final Version of Annex 16 to the EU Guide to Good Manufacturing Practice
Version 8 (final) EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single market, regulatory environment, industries under vertical legislation Pharmaceuticals and cosmetics Brussels, July 2001 Working
More informationGUIDELINES ON THE PRINCIPLES OF GOOD DISTRIBUTION PRACTICE OF ACTIVE SUBSTANCES FOR MEDICINAL PRODUCTS FOR HUMAN USE
PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PI 047-1 Annex 1 July 2018 GUIDELINES ON THE PRINCIPLES OF GOOD DISTRIBUTION PRACTICE OF ACTIVE SUBSTANCES FOR MEDICINAL
More informationClarity CDS since version 7.2 supportive tools for compliance with Title 21 CFR Part 11, EudraLex Chapter 4, Annex 11 and other similar legislation
Clarity CDS since version 7.2 supportive tools for compliance with Title 21 CFR Part 11, EudraLex Chapter 4, Annex 11 and other similar legislation Datasheet Introduction US Part 11 in Title 21 of Code
More informationGAMP5 Validation for Dynamics 365
GAMP5 Validation for Dynamics 365 Prepared by: Michael Webster, Business Development Director, RSM US LLP michael.webster@rsmus.com, +1 617 241 1544 Dynamics 365 is an ideal enterprise resource planning
More informationValidation of Commercial Computerised Systems using a Single Life Cycle Document (Integrated Validation Document)
Validation of Commercial Computerised Systems using a Single Life Cycle Document (Integrated Validation Document) R. D. McDowall McDowall Consulting, 73 Murray Avenue, Bromley, Kent, BR1 3DJ, UK Summary
More informationPRINCE2 - Quality Management Strategy
Created/updated 05/11/17 PRINCE2 - Quality Management Strategy Downloaded from stakeholdermap.com. Visit Prince2 Templates for more Prince2 downloads. Get a Mind Map Quality Management Strategy template
More informationEUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL
EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Medicinal Products Quality, Safety and Efficacy Brussels, 6 February 2014 SANCO/TSE/ The received contributions together with the identity of
More informationINFS 214: Introduction to Computing
INFS 214: Introduction to Computing Session 8 Application Software Lecturer: Dr. Ebenezer Ankrah, Dept. of Information Studies Contact Information: eankrah@ug.edu.gh College of Education School of Continuing
More informationOutsourcing - managing risks and opportunities over which you now have less control
Outsourcing - managing risks and opportunities over which you now have less control Kevin O Donnell, PhD PDA Meeting, Dublin 22 nd November 2018 Slide 2 Typical Examples The key GMP Requirements & Guidance
More informationComputer. Systems Validation. Full Time Part Time Online.
Computer Systems Validation Full Time Part Time Online www.dpseng.com.sg Contents 1. Welcome 2. Programme Overview 3. Programme Content www.dpseng.com.sg 2 Welcome Transition into a new career in the Pharmaceutical
More informationCompliance Response Electronic Records / Electronic Signatures (ERES) for SIMATIC PCS 7 V8.1
Compliance Response Electronic Records / Electronic Signatures (ERES) for SIMATIC PCS 7 V8.1 SIEMENS AG Industry Sector VSS Pharma D-76187 Karlsruhe, Germany E-Mail: pharma@siemens.com March 2015 A5E35829023-AA
More informationEHR Site Visit Questionnaire
HIM 3014 Health Information Technology Practicum EHR Assessment - Site Visit Questionnaire Student Name: Instructions: Schedule an EHR site visit and complete the following questionnaire by the date found
More informationIntroduction to 21 CFR 11 - Good Electronic Records Management
INTERNATIONAL JOURNAL OF ADVANCES IN PHARMACY, BIOLOGY AND CHEMISTRY Review Article Introduction to 21 CFR 11 - Good Electronic Records Management Pal Tapas Kumar* and Maity Subhasis NSHM Knowledge Campus,
More informationData Integrity Compliance Project
Data Integrity Compliance Project RISK FACTORS FOR DI ISSUES Outsourcing Supply Chain Data Review Practices Increasing use of electronic systems Economic Stressors 2 Fully Integrated into QMS DATA INTEGRITY
More information(Information) INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION
21.3.2015 EN Official Journal of the European Union C 95/1 II (Information) INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION Guidelines of 19 March 2015 on
More informationU.S. Technical Advisory Group to ISO/Technical Committee 207 Clarification of Intent of ISO 14001
Committee Correspondence US SUB-TAG to ISO/TC/207/SC1 on Environmental Management Systems Administrator: Jennifer Admussen, ASQ Chair: Susan L.K. Briggs When originating or replying, please send copy to
More informationPharmaceutical cgmps for the 21st Century February 2004
Pharmaceutical cgmps for the 21st Century February 2004 Ludwig Huber Compliance Fellow for Life Sciences and Chemical Analysis Chairperson: Rob Sample FDA GxP Regulations Along the Drug Life Basic Research
More informationHarmonizing Manufacturing across Multiple Sites and Regions
Harmonizing Manufacturing across Multiple Sites and Regions ISCT North America Regional Meeting Philadelphia, Pennsylvania Byron T. McAllister B.T. McALLISTER ASSOCIATES, INC. Tuesday, 10 September 2013
More informationEIOPA Common Application Package For Internal Models: Explanatory Note
November 2014 EIOPA Common Application Package For Internal Models: Explanatory Note 1. Introduction 1.1. EIOPA has published an Opinion 1 stating that National Competent Authorities ( NCAs ) should recommend
More information